Finland, Mexico report adverse effects to Pfizer vaccine; Argentina sees reactions to Sputnik V: Report – Moneycontrol

A 32-year-old doctor in Mexico has been admitted to the intensive care unit (ICU) due to severe medical allergy to the Pfizer-BioNTech vaccine

Representative image: Reuters/Marcos Brindicci

Representative image: Reuters/Marcos Brindicci

Countries that have begun their inoculation drives against the coronavirus have begun reporting cases of adverse reactions to Pfizer and BioNTech’s vaccine candidate and Russia’s Sputnik V.

Finland has reported its first adverse effect case due to the Pfizer-BioNTech vaccine on January 2. As per the Finnish Medicines Agency, there are “at least five such reports”, ANI reported.

Agency Chief Physician Maija Kaukonen said details of the same will be uploaded to their website, but no other information could be disclosed to maintain patient confidentiality.

Kaukonen noted that the number of such cases is likely to increase due to allergic or adverse reactions.

Follow our LIVE Updates on the coronavirus pandemic here

Meanwhile, a 32-year-old doctor in Mexico has been admitted to the intensive care unit (ICU) due to severe medical allergy to the Pfizer-BioNTech vaccine. The doctor developed rashes, suffered seizures, muscle weakness, breathing difficulties and possible encephalomyelitis within half an hour of vaccination, Mexico’s Health Ministry said on January 2, ANI reported.

While cause of the reaction is “being investigated” the patient has a history of allergic reactions to medication.

Check here for the latest updates on all COVID-19 vaccines

Pfizer-BioNTech’s doses are not the only one in the spotlight. Argentina’s Health Ministry on January 2 said only 1 percent of those who received doses of the Sputnik V vaccine developed mild adverse reactions to the shot, ANI reported.

The South American country acquired 300,000 doses, and 317 of the total 32,013 patients (mostly healthcare workers) who received the COVID-19 vaccine since December 29, have so far complained of fever and headaches, it added.

Russia claims Sputnik V is 92 percent effective based on data from 16,000 trial participants.

Follow our full COVID-19 coverage here

Moneycontrol News

Related post

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: